Bausch Health Companies (BHC) Net Income towards Common Stockholders (2009 - 2026)

Bausch Health Companies has disclosed Net Income towards Common Stockholders across 18 years of filings, most recently posting -$1.4 billion for Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at -$1.4 billion, down 1563.95% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 billion (down 1412.35% YoY), and the FY2025 annual result was $120.0 million, up 266.67% from the prior year.
• Net Income towards Common Stockholders came in at -$1.4 billion for Q1 2026 at Bausch Health Companies, down from -$103.0 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $403.0 million in Q3 2022 to a low of -$1.4 billion in Q1 2026.
• The 5-year median for Net Income towards Common Stockholders is -$77.0 million (2024), against an average of -$129.8 million.
• Across the five-year window, Net Income towards Common Stockholders soared 12900.0% in 2025 and slumped 1563.95% in 2026, its largest moves.
• Bausch Health Companies' Net Income towards Common Stockholders stood at -$410.0 million in 2022, then soared by 88.54% to -$47.0 million in 2023, then jumped by 308.51% to $98.0 million in 2024, then sank by 205.1% to -$103.0 million in 2025, then tumbled by 1289.32% to -$1.4 billion in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$1.4 billion (Q1 2026), -$103.0 million (Q4 2025), and $181.0 million (Q3 2025), per Business Quant data.